Advertisement

ADVERTISEMENT

Larry Blandford, PharmD—Column Editor

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model
Pharma Insights
Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model
09/18/2020
Maureen Hennessey, PhD, CPCC, CPHQ
Larry Blandford, PharmD—Column Editor
The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...
The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...
The...
09/18/2020
Journal of Clinical Pathways
Journeying Through the Past, Present, and Future of Medicare Part D
Pharma Insights
Journeying Through the Past, Present, and Future of Medicare Part D
06/17/2020
Andrew Cournoyer, RPh, MBA
Charline Shan, RPh, MPh
Larry Blandford, PharmD—Column Editor
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This...
06/17/2020
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
03/16/2020
Avi Mamidi, PharmD
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Jeremy Schafer, PharmD, MBA
Larry Blandford, PharmD—Column Editor
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways
Where Will Health Care Take Us in the 2020s?
Pharma Insights
Where Will Health Care Take Us in the 2020s?
02/18/2020
David Carr, PhD
Larry Blandford, PharmD—Column Editor
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we...
02/18/2020
Journal of Clinical Pathways
Pharma Insights
The Evolution of Value Frameworks and What Is Next
08/19/2019
Jeremy Schafer, PharmD, MBA
Larry Blandford, PharmD—Column Editor
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value...
08/19/2019
Journal of Clinical Pathways
Pharma Insights
Evolution of Hub Services
06/18/2019
Chris Dillon BS 
Chrysanthe Peteros, MPH
Larry Blandford, PharmD—Column Editor
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What...
06/18/2019
Journal of Clinical Pathways
Pharma Insights
The Health Care Ecosystem and Social Determinants of Health: Surveys Suggest the Stage Is Set for Novel Collaborations
05/15/2019
Maureen Hennessey, PhD, CPCC, CPHQ
Larry Blandford, PharmD—Column Editor
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr...
05/15/2019
Journal of Clinical Pathways
Pharma Insights
ACOs: Changing Health Care Cost and Quality to Be Accountable
12/13/2018
Marylou Buyse, MD, MS
Maureen Hennessey, PhD, CPCC, CPHQ
Larry Blandford, PharmD—Column Editor
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
...
12/13/2018
Journal of Clinical Pathways
Pharma Insights
Accreditation Explosion Among Top Specialty Pharmacy Trends
09/13/2018
Dominic Galante, MD, MS
Larry Blandford, PharmD—Column Editor
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the...
09/13/2018
Journal of Clinical Pathways
Pharma Insights
Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling
04/17/2018
Philip Cyr, MPH
Larry Blandford, PharmD—Column Editor
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
...
04/17/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Dermatology Week
November 13 ⁠–⁠ November 16
Psych Congress Primary Care Online Series
November 14 ⁠–⁠ November 15
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
December 9 ⁠–⁠ December 11
AIBD
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use